Start-Up Previews (07/2010)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Alzheimer's Start-Ups Face A Discovery And Clinical Crossroads," features profiles of AlzProtect, Axerion Therapeutics, Cognition Therapeutics and Galantos Pharma. "The Future of Laparoscopy: Single Incision, NOTES And Robots," features profiles of EndoControl, Ovesco Endoscopy, SurgiQuest and Virtual Incision. Plus these Start-Ups Across Health Care: Antabio, Beta-Stim, CMP Therapeutics, Elixir Medical, Kerecis, Optivia Biotechnology, Quanterix and reinnervate.
You may also be interested in...
The debate surrounding the future of minimally invasive surgery -- whether single-incision laparoscopy will prevail, or whether it is merely a stepping stone to a world of incisionless NOTES procedures - is not really relevant to Virtual Incision, a start-up developing mini surgical robots. The company's founders believe that in vivo robots will free a surgeon of any constraints due to the method of entering the body.
With technology licensed from the University of Tuebingen, Ovesco Endoscopy has set out to address one of the biggest challenges of NOTES procedures: achieving closure of the gastric wall while working through a flexible endoscope. Ovesco has developed a clipping system that imitates the mechanics - the geometry and force pattern - of a surgical suture, but with advantages.
The Marigen Lipid Enhanced Matrix from Kerecis Ltd. is derived from fish skin and has been shown to effectively improve the healing of wounds and surgical cuts. The company says that Marigen offers significant advantages over existing human and porcine-derived products, including improved manufacturing economics, lower risk of disease transfer and the promise of better clinical outcomes.
Sign in to continue reading.
Need a specific report?
1000+ reports available
New to In Vivo?
Start a free trial today!
Register for our free email digests: